PTGS2 and carcinoma: Although the overall COX-2 expression was 52.1%, the COX-2 expression by HGSC or type II carcinomas of 72% (18 of 25 cases) from the current study is in agreement with their study (p = 0.0038 for grade and 0.0097 for type II tumours).